In-hospital outcome for diabetic patients with acute myocardial infarction in the thrombolytic era

Scandinavian Cardiovascular Journal

Volumn 33, Issue 3, 1999, Pages 166-170

  Kjærgaard, Soøren Christensen ^b   Hansen, Hans Henrik Tilsted ^a   Fog, Lars ^b   Bülow, Inge ^b   Christensen, Per Dahl ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Complications; Diabetes; Heart failure; Mortality; Myocardial infarction

Indexed keywords

FIBRINOLYTIC AGENT; GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 0032815936     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017439950141803     Document Type: Article

References (28)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105-111.
2. Barbash GI, White HD, Modan M, Van de Werf F. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol 1993; 22: 707-713.
3. Czyzk A, Krolewski AS, Szablowska S, Alot A, Kopczynski J. Clinical course of myocardial infarction among diabetic patients. Diabetes Care 1980; 3: 526-529.
4. Fava S, Azzopardi J. Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993-16: 1615-1618.
5. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-322.
6. Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL. Myocardial infarct size and mortality in diabetic patients. Br Heart J 1985; 54: 466-472.
7. Lynch M, Gammage MD, Lamb P, Nattrass M. Pentecost BL. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med 1994; 11: 162-165.
8. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988; 9: 259-264.
9. Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996; 28: 1661-1669.
10. Rytter L, Troelsen S, Beck Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985; 8: 230-234.
11. Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984; 108: 31-37.
12. Karlson BW, Herlitz J, Hjalmarson A. Prognosis of acute myocardial infarction in diabetic and non-diabetic patients. Diabet Med 1993; 10: 449-454.
13. Stone PH, Muller JE, Hartwell T, et al., for the MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989; 14: 49-57.
14. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993; 22: 1788-1794.
15. Granger CB, Califf RM, Young S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993; 21: 920-925.
16. Pfeffer MA, Moye LA, Braunwald E, et al., for the SAVE Investigators. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991; 266: 528-532.
17. Hansen HH, Kjaergaard SC, Bulow I, Fog L, Christensen PD. Thrombolytic therapy in diabetic patients with acute myocardial infarction. Diabetes Care 1996; 19: 1135-1137.
18. O'Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Maurer BJ. Silent ischaemia in diabetic men with autonomic neuropathy. Br Heart J 1991; 66: 313-315.
19. Orlander PR, Goff DC, Morissey M, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial survival in Mexican-American and non-Hispanic whites: the Corpus Christi Heart Project. Diabetes 1994; 43: 897-902.
20. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 1989; 118: 1000-1012.
21. Mak KH, Moliterno DJ, Granger CB, et al., for the GUSTO-1 Investigators. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol 1997; 30: 171-179.
22. Barbash GI, White HD, Modan M, Van de Werf F, for the investigators of the international tissue plasminogen activator/streptokinase mortality trial. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 1993; 22: 707-713.
23. Karlsberg R, Cryer P, Roberts R. Serial plasma catecholamine response early in course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 1981; 102: 24-29.
24. Vetter N, Strange R, Adams W, Oliver M. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 2: 284-289.
25. Tansey M, Opie L. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet 1983; 1: 419-422.
26. Clark RS, English M, McNeill GP, Newton RW. Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction. Br Med J Clin Res Ed 1985; 291: 303-305.
27. Gwilt DJ, Petri M, Lamb P, Nattrass M, Pentecost BL. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984; 51: 626-630.
28. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.